medical and laboratory supplies
Search documents
Why Cardinal Health May Be a Best Buy for the Coming Stagflation
Yahoo Finance· 2026-03-06 16:45
Company Overview - Cardinal Health is a global leader in healthcare services and products, operating in two main segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution [4] - The company delivers a wide range of pharmaceuticals and medical supplies to over 90% of U.S. hospitals and various healthcare facilities [4] Financial Performance - In the fiscal second quarter, Cardinal Health's sales increased by 19% to $65.6 billion, with earnings per share rising to $1.97 [5] - Analysts project a 16% annual growth in EPS for the next five years, highlighting the company's strong position in the healthcare supply chain [5] Market Position and Demand - Cardinal Health's business model benefits from inelastic demand for prescription drugs and medical supplies, making it resilient during economic downturns [8] - The company manages 40,000 pharmaceutical deliveries daily, ensuring a steady supply to hospitals and pharmacies [5] Dividend and Shareholder Returns - Cardinal Health has a long history of rewarding shareholders, having paid dividends for over four decades and increased its payout for 31 consecutive years, qualifying it as a Dividend Aristocrat [7] - The current annual dividend is $2.04 per share, yielding 0.93%, with a conservative payout ratio of approximately 30% [7] Investment Outlook - In the current economic environment characterized by stagflation, Cardinal Health is viewed as a strong investment due to its defensive characteristics and essential demand [3][8]